{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T18:42:16Z","timestamp":1789843336823,"version":"4.0.1"},"reference-count":42,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","theclinics.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Dermatologic Clinics"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.det.2024.02.009","type":"journal-article","created":{"date-parts":[[2024,3,15]],"date-time":"2024-03-15T14:06:40Z","timestamp":1710511600000},"page":"507-512","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Disparities in Care for Psoriasis"],"prefix":"10.1016","volume":"42","author":[{"given":"Roman","family":"Drozdowski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neelesh","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Gronbeck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.det.2024.02.009_bib1","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.jaad.2021.12.062","article-title":"Racial\/Ethnic Health Disparities in Dermatology in the United States Part 2: Disease-specific Epidemiology, Characteristics, Management, and Outcomes","volume":"87","author":"Shao","year":"2022","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.det.2024.02.009_bib2","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.jaad.2008.09.022","article-title":"The prevalence of previously diagnosed and undiagnosed psoriasis in US adults: Results from NHANES 2003-2004","volume":"60","author":"Kurd","year":"2009","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.det.2024.02.009_bib3","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1471-5945-14-13","article-title":"Low rate of dermatology outpatient visits in Asian-Americans: an initial survey study for associated patient-related factors","volume":"14","author":"Lingala","year":"2014","journal-title":"BMC Dermatol"},{"key":"10.1016\/j.det.2024.02.009_bib4","doi-asserted-by":"crossref","first-page":"2955","DOI":"10.1038\/jid.2015.296","article-title":"Psoriasis in the US Medicare Population: Prevalence, Treatment, and Factors Associated with Biologic Use","volume":"135","author":"Takeshita","year":"2015","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.det.2024.02.009_bib5","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1080\/09546634.2020.1820936","article-title":"Language proficiency and biologics access: a population study of psoriasis patients in the United States","volume":"33","author":"Chat","year":"2022","journal-title":"J\u00a0Dermatol Treat"},{"key":"10.1016\/j.det.2024.02.009_bib6","doi-asserted-by":"crossref","first-page":"adv00354","DOI":"10.2340\/00015555-3711","article-title":"Effect of Sex in Systemic Psoriasis Therapy: Differences in Prescription, Effectiveness and Safety in the BIOBADADERM Prospective Cohort","volume":"101","author":"Hern\u00e1ndez-Fern\u00e1ndez","year":"2021","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.det.2024.02.009_bib7","doi-asserted-by":"crossref","first-page":"91","DOI":"10.2340\/00015555-2483","article-title":"Gender, Body Image and Social Support: Biopsychosocial Determinants of Depression Among Patients with Psoriasis","volume":"97","author":"Wojtyna","year":"2017","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.det.2024.02.009_bib8","first-page":"846","article-title":"Biologic and Conventional Systemic Therapies Show Similar Safety and Efficacy in Elderly and Adult Patients With Moderate to Severe Psoriasis","volume":"14","author":"Garber","year":"2015","journal-title":"J\u00a0Drugs Dermatol JDD"},{"key":"10.1016\/j.det.2024.02.009_bib9","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1016\/j.jaad.2019.10.014","article-title":"Where you live matters: Regional differences in health care resource use for psoriasis in the United States","volume":"82","author":"Nguyen","year":"2020","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.det.2024.02.009_bib10","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jaad.2016.03.048","article-title":"The inpatient burden of psoriasis in the United States","volume":"75","author":"Hsu","year":"2016","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.det.2024.02.009_bib11","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.jaad.2016.10.045","article-title":"Variation in dermatologist visits by sociodemographic characteristics","volume":"76","author":"Mulcahy","year":"2017","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.det.2024.02.009_bib12","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1001\/jamadermatol.2021.2007","article-title":"Psoriasis Prevalence in Adults in the United States","volume":"157","author":"Armstrong","year":"2021","journal-title":"JAMA Dermatology"},{"key":"10.1016\/j.det.2024.02.009_bib13","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1007\/s10067-014-2763-3","article-title":"Psoriasis and psoriatic arthritis in African-American patients\u2014the need to measure disease burden","volume":"34","author":"Kerr","year":"2015","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.det.2024.02.009_bib14","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1016\/j.jaad.2022.06.1193","article-title":"Variations in genetics, biology, and phenotype of cutaneous disorders in skin of color \u2013 Part I: Genetic, biologic, and structural differences in skin of color","volume":"87","author":"Brown-Korsah","year":"2022","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.det.2024.02.009_bib15","first-page":"AB128","article-title":"A\u00a0retrospective study to investigate ethnic variations in the treatment of psoriasis with etanercept","volume":"58","year":"2008","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.det.2024.02.009_bib16","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1001\/jamadermatol.2022.2426","article-title":"Differences in Face-to-Face Time Spent With a Dermatologist Among Patients With Psoriasis Based on Race and Ethnicity","volume":"158","author":"Wu","year":"2022","journal-title":"JAMA Dermatology"},{"key":"10.1016\/j.det.2024.02.009_bib17","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.jaad.2017.02.042","article-title":"Ethnicity affects the presenting severity of psoriasis","volume":"77","author":"Abrouk","year":"2017","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.det.2024.02.009_bib18","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1136\/annrheumdis-2022-eular.212","article-title":"AB0922 Psoriatic Arthritis Disease Activity Differs by Race\/Ethnicity","volume":"81","author":"Ahmed","year":"2022","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.det.2024.02.009_bib19","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.jaad.2017.07.052","article-title":"Health care utilization for psoriasis in the United States differs by race: An analysis of the 2001-2013 Medical Expenditure Panel Surveys","volume":"78","author":"Fischer","year":"2018","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.det.2024.02.009_bib20","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jaad.2004.07.045","article-title":"The prevalence of psoriasis in African Americans: Results from a population-based study","volume":"52","author":"Gelfand","year":"2005","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.det.2024.02.009_bib21","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.jaad.2018.02.050","article-title":"The risk of cardiovascular events in psoriasis patients treated with tumor necrosis factor\u2013\u03b1 inhibitors versus phototherapy: An observational cohort study","volume":"79","author":"Wu","year":"2018","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.det.2024.02.009_bib22","first-page":"1162","article-title":"Biologics for Reducing Cardiovascular Risk in Psoriasis Patients","volume":"12","author":"Terui","year":"2023","journal-title":"J\u00a0Clin Med"},{"key":"10.1016\/j.det.2024.02.009_bib23","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/bjd.19876","article-title":"Biologics utilization for psoriasis is lower in black compared with white patients","volume":"185","author":"Hodges","year":"2021","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.det.2024.02.009_bib24","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1016\/j.jid.2018.12.032","article-title":"Racial Differences in Perceptions of Psoriasis Therapies: Implications for Racial Disparities in Psoriasis Treatment","volume":"139","author":"Takeshita","year":"2019","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.det.2024.02.009_bib25","doi-asserted-by":"crossref","first-page":"e12","DOI":"10.1056\/NEJMpv2035827","article-title":"Beyond Tuskegee \u2014 Vaccine Distrust and Everyday Racism","volume":"384","author":"Bajaj","year":"2021","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.det.2024.02.009_bib26","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1353\/hpu.0.0323","article-title":"More than Tuskegee: Understanding Mistrust about Research Participation","volume":"21","author":"Scharff","year":"2010","journal-title":"J\u00a0Health Care Poor Underserved"},{"key":"10.1016\/j.det.2024.02.009_bib28","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1016\/j.jaad.2022.09.006","article-title":"Disparities in psoriasis clinical trials: A cross-sectional analysis","volume":"87","author":"Ding","year":"2022","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.det.2024.02.009_bib29","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/j.jaad.2021.08.038","article-title":"Racial disparities in clinical trials of biologic treatments for psoriatic arthritis","volume":"87","author":"Shwe","year":"2022","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.det.2024.02.009_bib30","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1001\/jamadermatol.2016.4129","article-title":"Diversity in Dermatology Clinical Trials: A Systematic Review","volume":"153","author":"Charrow","year":"2017","journal-title":"JAMA Dermatology"},{"issue":"8","key":"10.1016\/j.det.2024.02.009_bib31","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1007\/s00403-023-02633-2","article-title":"Differential patient travel distance and time to psoriasis clinical trial sites","volume":"315","author":"Masison","year":"2023","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.det.2024.02.009_bib32","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1111\/jdv.15733","article-title":"Female patients are less satisfied with biological treatment for psoriasis and experience more side-effects than male patients: results from the prospective BioCAPTURE registry","volume":"33","author":"LSvd","year":"2019","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.det.2024.02.009_bib33","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/bjd.19169","article-title":"Systematic review examining changes over time and variation in the incidence and prevalence of psoriasis by age and gender","volume":"184","author":"Iskandar","year":"2021","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.det.2024.02.009_bib34","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1111\/ced.14258","article-title":"Real-life efficacy and safety of secukinumab in elderly patients with psoriasis over a 2-year period","volume":"45","author":"Megna","year":"2020","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.det.2024.02.009_bib35","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/jdv.12850","article-title":"Psoriasis in the elderly: epidemiological and clinical aspects, and evaluation of patients with very late onset psoriasis","volume":"30","author":"Phan","year":"2016","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.det.2024.02.009_bib36","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s40266-014-0156-6","article-title":"Managing Moderate-to-Severe Psoriasis in the Elderly","volume":"31","author":"Balato","year":"2014","journal-title":"Drugs Aging"},{"key":"10.1016\/j.det.2024.02.009_bib37","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/j.jaad.2020.10.015","article-title":"Trends in Medicare Part D prescription claims for biologic and nonbiologic immunosuppressive medications by dermatologists","volume":"84","author":"Gronbeck","year":"2021","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.det.2024.02.009_bib38","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1007\/s00403-022-02410-7","article-title":"Equity in the usage of biologics for psoriasis in the working poor","volume":"315","author":"Eley","year":"2023","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.det.2024.02.009_bib39","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1001\/archdermatol.2012.804","article-title":"Disparities in access to dermatologic care according to insurance type","volume":"148","author":"Alghothani","year":"2012","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.det.2024.02.009_bib40","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/j.jaad.2021.12.017","article-title":"Poor coverage of psoriasis biologics in a cross-sectional analysis of Medicaid formularies","volume":"87","author":"Falotico","year":"2022","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.det.2024.02.009_bib41","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1001\/jama.2022.14791","article-title":"The US Medicaid Program: Coverage, Financing, Reforms, and Implications for Health Equity","volume":"328","author":"Donohue","year":"2022","journal-title":"JAMA"},{"key":"10.1016\/j.det.2024.02.009_bib42","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.det.2019.08.006","article-title":"Phototherapy in Skin of Color","volume":"38","author":"Ware","year":"2020","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.det.2024.02.009_bib43","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.jaad.2020.04.095","article-title":"Role of phototherapy in the era of biologics","volume":"84","author":"Torres","year":"2021","journal-title":"J\u00a0Am Acad Dermatol"}],"container-title":["Dermatologic Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733863524000214?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733863524000214?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,23]],"date-time":"2024-05-23T21:39:06Z","timestamp":1716500346000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0733863524000214"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":42,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["S0733863524000214"],"URL":"https:\/\/doi.org\/10.1016\/j.det.2024.02.009","relation":{},"ISSN":["0733-8635"],"issn-type":[{"value":"0733-8635","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Disparities in Care for Psoriasis","name":"articletitle","label":"Article Title"},{"value":"Dermatologic Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.det.2024.02.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}